Guangdong Biolight Meditech Co., Ltd. (SHE:300246)
China · Delayed Price · Currency is CNY 17.38
+0.37 (2.18%)
Apr 30, 2026, 1:55 PM CST
SHE:300246 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -87.17 | -65.41 | -71.44 | -65.19 | 22.13 | 63.79 |
Depreciation & Amortization | 76.03 | 76.03 | 66.89 | 58.12 | 51.24 | 40.5 |
Other Amortization | 8.57 | 8.57 | 11.62 | 9.44 | 8.17 | 5.2 |
Loss (Gain) From Sale of Assets | 0.62 | 0.62 | -0.03 | 0.31 | -0.51 | -0.92 |
Asset Writedown & Restructuring Costs | 35.05 | 35.05 | 20.82 | 114.55 | 0.01 | 9.54 |
Loss (Gain) From Sale of Investments | -8.01 | -8.01 | -9.99 | -10.31 | -9.98 | 0.45 |
Provision & Write-off of Bad Debts | - | - | 4.5 | 6.32 | 6.5 | 3.52 |
Other Operating Activities | 73.06 | 38.57 | 37.27 | 29.71 | 19.26 | 18.38 |
Change in Accounts Receivable | -186.8 | -186.8 | 27.39 | -42.69 | -58.27 | -50.72 |
Change in Inventory | -63.38 | -63.38 | -21.97 | -26.78 | -6.15 | -45.95 |
Change in Accounts Payable | 269.94 | 269.94 | -62.49 | 52.24 | 109.61 | 27.85 |
Change in Other Net Operating Assets | - | - | - | -4.89 | 7.3 | 13.25 |
Operating Cash Flow | 103.17 | 90.44 | -8.64 | 129.05 | 140.72 | 80.61 |
Operating Cash Flow Growth | - | - | - | -8.30% | 74.56% | -82.31% |
Capital Expenditures | -153.89 | -167.46 | -103.81 | -220.33 | -211.8 | -163.41 |
Sale of Property, Plant & Equipment | 0.45 | 12.66 | 0.49 | 0.03 | 4.49 | 3.62 |
Cash Acquisitions | - | - | - | -1.03 | - | -0.09 |
Divestitures | - | - | 0.18 | - | - | - |
Investment in Securities | -112.2 | 225 | 59.37 | 30 | -289.4 | -21.3 |
Other Investing Activities | 0.37 | 26.31 | 8.35 | 1.09 | 0.3 | -11.99 |
Investing Cash Flow | -265.26 | 96.51 | -35.43 | -190.24 | -496.41 | -193.17 |
Long-Term Debt Issued | - | 371.5 | 427.53 | 371.04 | 204.59 | 215.89 |
Total Debt Issued | 331.05 | 371.5 | 427.53 | 371.04 | 204.59 | 215.89 |
Short-Term Debt Repaid | - | - | - | - | - | -29.57 |
Long-Term Debt Repaid | - | -304.08 | -374.55 | -175.1 | -168.71 | -128.9 |
Total Debt Repaid | -268.02 | -304.08 | -374.55 | -175.1 | -168.71 | -158.47 |
Net Debt Issued (Repaid) | 63.03 | 67.42 | 52.98 | 195.94 | 35.89 | 57.42 |
Issuance of Common Stock | - | - | - | 7.87 | 543.87 | - |
Repurchase of Common Stock | - | - | -20.01 | - | - | - |
Common Dividends Paid | -30.99 | -30.65 | -17.62 | -46.35 | -40.83 | -58.35 |
Other Financing Activities | -4.27 | 3.27 | 6.28 | -39.91 | -52.23 | -43.56 |
Financing Cash Flow | 27.77 | 40.04 | 21.63 | 117.55 | 486.7 | -44.5 |
Foreign Exchange Rate Adjustments | -11.63 | -6.16 | 3.47 | 1.18 | 4.78 | -1.21 |
Net Cash Flow | -145.95 | 220.83 | -18.98 | 57.53 | 135.8 | -158.27 |
Free Cash Flow | -50.72 | -77.02 | -112.45 | -91.29 | -71.08 | -82.8 |
Free Cash Flow Margin | -4.65% | -7.03% | -10.60% | -7.65% | -6.00% | -7.59% |
Free Cash Flow Per Share | -0.19 | -0.29 | -0.43 | -0.35 | -0.27 | -0.38 |
Cash Income Tax Paid | - | -6.79 | 8.51 | 20.72 | 7.48 | 30.71 |
Levered Free Cash Flow | -75.69 | -124.08 | -189.62 | -89.93 | -130.32 | -124.77 |
Unlevered Free Cash Flow | -75.69 | -124.08 | -172.51 | -80.63 | -123.13 | -117.29 |
Change in Working Capital | 5.03 | 5.03 | -68.27 | -13.91 | 43.89 | -59.83 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.